Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 October 2011 :

Rosiglitazone protects against severe hemorrhagic shock-induced organ damage in rats

DOI: 10.12659/MSM.881975

Med Sci Monit 2011; 17(10): BR282-289

Related articles

30 Oct 2019 : Animal Research

Higher Concentration of Hypertonic Saline Shows Better Recovery Effects on Rabbits with Uncontrolled Hemorrhagic Shock

Lei Xu, Fengjuan Kang [...]

DOI: 10.12659/MSM.916937

Med Sci Monit 2019; 25:8120-8130

298 4 4

06 Sep 2018 : Laboratory Research

Rosiglitazone Reduces Apoptosis and Inflammation in Lipopolysaccharide-Induced Human Umbilical Vein Endothelial Cells

Xiao-xia Ji, Xiao-jing Ji [...]

DOI: 10.12659/MSM.910036

Med Sci Monit 2018; 24: LBR6200-6207

366 3 37

11 Mar 2014 : Original article

L-carnosine alters some hemorheologic and lipid peroxidation parameters in nephrectomized rats

Hande Yapislar, Eylem Taskin

DOI: 10.12659/MSM.890528

Med Sci Monit 2014; 20:399-405

375 1 21

01 Dec 2011

Hemorrhagic shock caused by sigmoid colon volvulus: An autopsy case

Hiroaki Sato, Toshiko Tanaka [...]

DOI: 10.12659/MSM.882113

Med Sci Monit 2011; 17(12): CS145-148

312 1 12

29 Apr 2008

Role of tumor necrosis factor-alpha and interleukin-1beta on lung dysfunction following hemorrhagic shock in rats

Hiroaki Sato, Kentaro Kasai [...]

Med Sci Monit 2008; 14(5): BR79-87

316 3 9

08 May 2018 : Animal Research

Sodium Tanshinone IIA Sulfonate Improves Hemodynamic Parameters, Cytokine Release, and Multi-Organ Damage in Endotoxemia Rabbits

Shaolei Ma, Xian Wang [...]

DOI: 10.12659/MSM.909996

Med Sci Monit 2018; 24: ANS2975-2982

382 3 16

30 Dec 2008

Rosiglitazone, a peroxisome proliferator-activated receptor gamma (PPARgamma)-specific agonist, as a modulator in experimental acute pancreatitis

Krzysztof Celiński, Agnieszka Mądro [...]

Med Sci Monit 2009; 15(1): BR21-29

221 3 34

29 May 2008

Database assessment of the effectiveness of brand versus generic rosiglitazone in patients with type 2 diabetes mellitus

Ronen Loebstein, Itzhak Katzir [...]

Med Sci Monit 2008; 14(6): CR323-326

284 1 15

01 Apr 2008

Rosiglitazone in the prevention of diabetes and cardiovascular disease: Dream or reality?

Tomas Stulc, Richard Ceska

Med Sci Monit 2008; 14(4): RA45-47

227 1 9

22 Dec 2005

The impact of rosiglitazone on cardiovascular responses and endurance during isometric exercise in patients with Type 2 Diabetes.

Jerrold Scott Petrofsky, Scott Lee

Med Sci Monit 2006; 12(1): CR21-26

246 8 17

01 Dec 2005

The impact of rosiglitazone on heat tolerance in patients with Type 2 Diabetes.

Jerrold Petrofsky, Scott Lee [...]

Med Sci Monit 2005; 11(12): CR562-569

276 3 10

01 Jun 2005 : Original article

Gait characteristics in patients with type 2 diabetes; improvement after administration of rosiglitazone

Jerrold S. Petrofsky, Scott Lee [...]

Med Sci Monit 2005; 11(6): PI43-51

286 8 16

01 Mar 2004

The metabolic effects of insulin and rosiglitazone combination therapy in Chinese Type 2 diabetic patients with nephropathy

Norman N. Chan, Peter C.Y. Tong [...]

Med Sci Monit 2004; 10(3): PI44-48

235 0 13

Editorial

15 August 2022 : Editorial  

Editorial: The Metabolic (Dysfunction) Associated Fatty Liver Disease (MAFLD)-Non-Alcoholic Fatty Liver Disease (NAFLD) Debate: A Forced Consensus and The Risk of a World Divide

Nahum Méndez-Sánchez, Ming-Hua Zheng, Takumi Kawaguchi, Shiv K. Sarin
Liver Research Unit, Medica Sur Clinic & Foundation and Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico

DOI: 10.12659/MSM.938080

Med Sci Monit 2022; 28:e938080

SARS-CoV-2/COVID-19

18 August 2022 : Database Analysis  

Transcriptome Analysis of Peripheral Blood Mononuclear Cells Response in Patients with Severe COVID-19 Reve...

Med Sci Monit In Press; DOI: 10.12659/MSM.937532  

In Press

18 Aug 2022 : Database Analysis  

Transcriptome Analysis of Peripheral Blood Mononuclear Cells Response in Patients with Severe COVID-19 Reve...

Med Sci Monit In Press; DOI: 10.12659/MSM.937532  

18 Aug 2022 : Clinical Research  

Comparison of Local and Systemic Ibuprofen for Relief of Postoperative Pain in Symptomatic Teeth with Apica...

Med Sci Monit In Press; DOI: 10.12659/MSM.937339  

18 Aug 2022 : Clinical Research  

Cross-Cultural Adaptation of the Godin-Shephard Leisure-Time Physical Activity Questionnaire for Arabic Pop...

Med Sci Monit In Press; DOI: 10.12659/MSM.937245  

12 Aug 2022 : Clinical Research  

Risk Factors and Pathogen Spectrum in Continuous Ambulatory Peritoneal Dialysis-Associated Peritonitis: A S...

Med Sci Monit In Press; DOI: 10.12659/MSM.937112  

Most Viewed Current Articles

30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

13 Nov 2021 : Clinical Research  

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292

01 Nov 2020 : Review article  

Long-Term Respiratory and Neurological Sequelae of COVID-19

DOI :10.12659/MSM.928996

Med Sci Monit 2020; 26:e928996

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750